Syed Mohammad Ali Kazmi

9PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyPublic health nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 23, 2026
Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial.

|Jan 07, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Kristen K Ciombor, Lianchun Xiao

|May 01, 2025
Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer.

Peter Q Leung, Eslam A Elghonaimy, Ahmed M Elamir

|Jan 06, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.

Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan

|May 22, 2023
Characteristics and clinical outcomes in young-onset cholangiocarcinoma.

Sarah Reddy, Suleyman Yasin Goksu, Nina N Sanford

|Sep 09, 2022
Trends in utilization of first-line palliative treatments for anal squamous cell carcinoma.

Srinidhi J Radhakrishnan, Suleyman Y Goksu, Saikripa M Radhakrishnan

Pageof 2

Frequent Collaborators

4 joint publications

Suleyman Yasin Goksu

4 joint publications

Nina N Sanford

3 joint publications

Muhammad Shaalan Beg

2 joint publications

Todd A Aguilera